The future here isn't written in the past. What you should be focusing on are the additional 3 revenue streams to come shortly that will multiply revenue. Japan sales late 2022. Vitiligo and Soft Tissue late 2023. It adds up. That's where you'll find the potential. Not only will you get more streams, but you'll get more penetration with the ease of use gained from the new Recell device.
AVH Price at posting:
$1.60 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)